TTR GalNAc-siRNA (Alnylam)

N/A

Report date: 2025/01/26 15:56:59
NME

Base Information

Drug NameTTR GalNAc-siRNA (Alnylam)
Drug Alias NameTTR gene-silencing siRNA therapy (Alnylam)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionTransthyretin inhibitors
TargetsTransthyretin
Therapy Area/IndicationsAmyloid Neuropathies, Familial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAlnylam Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesAlnylam Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsAmyloid Neuropathies, Familial
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A